Agios Pharmaceuticals Cash from Investing (TTM) Analysis

Agios Pharmaceuticals Inc (AGIO)

31.48 -0.19 (-0.60%) USD | NASDAQ | Apr 26, 16:00

31.48 0.00 (0.00%) After-Hours: 18:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	239.58M
September 30, 2023	227.01M
June 30, 2023	291.74M
March 31, 2023	327.43M
December 31, 2022	243.26M
September 30, 2022	65.89M
June 30, 2022	-270.91M
March 31, 2022	-651.87M
December 31, 2021	1.249B
September 30, 2021	1.415B
June 30, 2021	1.521B
March 31, 2021	1.842B
December 31, 2020	75.75M
September 30, 2020	-180.42M
June 30, 2020	26.20M
March 31, 2020	68.22M
December 31, 2019	91.44M
September 30, 2019	263.41M
June 30, 2019	185.80M
March 31, 2019	25.06M
December 31, 2018	-273.82M
September 30, 2018	-219.17M
June 30, 2018	-155.53M

Date	Value
March 31, 2018	-334.99M
December 31, 2017	-57.91M
September 30, 2017	-177.27M
June 30, 2017	-306.44M
March 31, 2017	5.03M
December 31, 2016	-119.35M
September 30, 2016	-20.87M
June 30, 2016	72.03M
March 31, 2016	68.49M
December 31, 2015	128.31M
September 30, 2015	-179.95M
June 30, 2015	-225.21M
March 31, 2015	-276.08M
December 31, 2014	-333.34M
September 30, 2014	-66.44M
June 30, 2014	-132.07M
March 31, 2014	-103.52M
December 31, 2013	-87.22M
September 30, 2013	-46.97M
June 30, 2013	32.03M
March 31, 2013	16.69M
December 31, 2012	23.04M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-651.87M

Minimum

Mar 2022

1.842B

Maximum

Mar 2021

369.93M

Average

227.01M

Median

Sep 2023

Cash from Investing (TTM) Benchmarks